News for BARD1 Life Sciences Limited (BD1.AX)

Published at

Jul 26, 2022 4:34 AM

by stockhead.com.au

positive

positive

ASX Health Stocks: INOVIQ reports good study results; Mayne Pharma launches unique oral contraceptive

Diagnostics and exosome specialist INOVIQ (ASX:IIQ) says that a feasibility study to evaluate the use of SubB2M has been completed.

MYX.AX GSS.AX BD1.AX

Read more →
Published at

Jul 22, 2022 4:51 AM

by stockhead.com.au

positive

positive

ASX Health Stocks: Inoviq pockets another US patent, its second in a month

Diagnostics and exosome specialist Inoviq (ASX:IIQ) has been granted a US patent for its hTERT test platform.

BD1.AX

Read more →
Published at

Jan 17, 2022 6:37 AM

by stockhead.com.au

mixed

mixed

Closing Bell: ASX gains ground as fintech IPO Beforepay goes belly-up

Local stocks gained ground on Monday, while high-profile fintech IPO Beforepay fell sharply on debut with a drop of +40%.

YPB.AX VPR.AX SUH.AX MLS.AX LM8.AX GTN.AX DXN.AX ARO.AX ADV.AX TNR.AX TI1.AX SI6.AX NAE.AX MSCL.SN MCM.AX GTG.AX GENE FNT.AX ESS.AX BWNAF ARR.AX AO1.AX AMDHF ABC.AX PNN.AX NET.AX HNR.AX BD1.AX APT.AX

Read more →
Published at

Dec 8, 2021 8:27 PM

by stockhead.com.au

mixed

mixed

Check Up: Neuren close to FDA drug approval and Compumedics fires up Aussie factory for medical wearables

Neuren plans New Drug Application, and Compumedics targets manufacturing of wearable medical-grade monitoring technology in Australia.

PGC.AX PBP.AX NEU.AX KZIA KZA.AX IVX.AX IDT.AX DXB.AX CAJ.AX BPH.AX BITRF BIT.AX BD1.AX AT1.AX VLS.AX UBI.AX TD1.AX SOMNF SOM.AX SCU.AX RHT.AX RAP.AX PAL.AX OVN.AX OSX.AX OSL.AX ONE.AX OIL.AX OCC.AX NXSCF NXS.AX NOXOF NOX.AX NC6.AX MXC.AX MEB.AX MDR.AX MDBIF LBT.AX IUGNF IMU.AX IMRNW IMRN IMMP IMM.AX IMC.AX ICR.AX GTG.AX GLH.AX GENE FDMDF DVL.AX CYP.AX CPH.AX CMP.AX CGS.AX CAN.AX BXN.AX ATX.AX ARUXF AMT.AX ALT.AX ACR.AX 4DX.AX ZNO.AX ZLD.AX VTG.AX RSH.AX RNO.AX RHY.AX RGS.AX RAC.AX PYC.AX PXSLY PXS.AX PSQ.AX PNV.AX PCK.AX PAB.AX OPT.AX OPT NYR.AX MX1.AX MVF.AX MEM.AX MDC.AX KMLXF IPDQF IPD.AX IHL.AX HCT.AX GSS.AX FFC.AX EYE.AX CKDXF CALZF BWXXF BWX.AX BNOEF BNO.AX ARX.AX AMDHF ALC.AX ADR.AX ADO.AX 1ST.AX 1AD.AX

Read more →
Published at

Nov 29, 2021 6:33 AM

by stockhead.com.au

mixed

mixed

Closing Bell: ASX makes up lost ground, still finishes 0.54% down

After a drop of over 1% in the morning, the ASX recovered some of the lost ground in the afternoon but still finished 0.54% down.

WEL.AX TG1.AX STX.AX PPT.AX OVT.AX NCL.AX N1H.AX MRR.AX MR1.AX MLS.AX MKG.AX MHK.AX LCK.AX KEY.AX GRV.AX GED.AX GBE.AX FRI.AX FRB.AX EVE.AX ERG.AX EPN.AX EMR.AX CGR.AX CGB.AX CAN.AX BXN.AX BITRF BIT.AX BD1.AX BCK.AX AUR.AX AUQ.AX AFL.AX ACW.AX VPR.AX SFM.AX FIN.AX AUH.AX RFF.AX

Read more →
Published at

Nov 24, 2021 8:13 PM

by stockhead.com.au

mixed

mixed

Check Up: Sustainable Nutrition riding high and Singular Health branches out from… health

Singular Health branches out for diversified revenue sources, while Sustainable Nutrition Group wants its hemp product commercialised .

RHY.AX OVN.AX ONE.AX MEM.AX IVX.AX IMM.AX IHL.AX GTG.AX EYE.AX CPH.AX BWXXF BWX.AX BPH.AX BITRF BIT.AX ARX.AX ARUXF AMT.AX ACR.AX 1AD.AX ZLD.AX SOMNF SOM.AX SCU.AX RSH.AX RNO.AX RHT.AX RGS.AX RAP.AX RAC.AX PYC.AX PXSLY PXS.AX PIQ.AX PGC.AX PBP.AX OSL.AX NC6.AX MXC.AX KZA.AX KMLXF IUGNF IMU.AX IDT.AX ICR.AX HCT.AX FDMDF DXB.AX BD1.AX ATX.AX AT1.AX 4DX.AX ZNO.AX VTG.AX VLS.AX UBI.AX TD1.AX SHG.AX PSQ.AX PNV.AX PCK.AX PAL.AX PAB.AX OSX.AX OPT.AX OPT OIL.AX OCC.AX NYR.AX NXSCF NXS.AX NOXOF NOX.AX MX1.AX MVF.AX MEB.AX MDR.AX MDC.AX MDBIF LBT.AX IPDQF IPD.AX IMRNW IMRN IMC.AX GSS.AX GLH.AX FFC.AX DVL.AX CYP.AX CMP.AX CKDXF CGS.AX CAN.AX CALZF CAJ.AX BXN.AX BNOEF BNO.AX AMDHF ALC.AX ADR.AX ADO.AX 1ST.AX

Read more →
Published at

Nov 22, 2021 5:24 AM

by marketscreener.com

positive

positive

BARD1 Life Sciences : Notification regarding unquoted securities - BD1

Notification of Issue, Conversion or Payment up of Unquoted Equity Securities Announcement Summary ... | November 22, 2021

BD1.AX

Read more →
Published at

Nov 15, 2021 6:24 AM

by stockhead.com.au

mixed

mixed

Closing Bell: Gold stocks catch a bid, and another green hydrogen play surges +300% in a week

ASX green hydrogen stocks continue to run hot, with ECT surging for the fifth straight session today with a +50% gain.

WWI.AX WC8.AX RDN.AX PYC.AX PNR.AX OVT.AX OIEXF OEX.L OEX.AX OAU.AX NOX.AX MRR.AX LIO.AX KOR.AX HLA.AX HAW.AX GRV.AX FGL.AX EFE.AX ECT.AX DRE.AX DEV.AX CSE.AX CIM.AX AUH.AX ANL.AX AKN.AX 1ST.AX YPB.AX VR1.AX PXS.AX PLY.AX NPM.AX NNG.AX MRZ.AX MCA.AX LER.AX LCY.AX IVX.AX ICNOF ICN.AX GBE.AX ERG.AX EMP.AX CLE.AX AUK.AX AUA.AX BD1.AX

Read more →
Published at

Nov 14, 2021 7:48 PM

by stockhead.com.au

mixed

mixed

Rise and Shine: What you need to know before the ASX opens

How to invest in decarbonisation, the ASX stocks with highest and lowest P/E ratio, and why ESG is a good bet.

XTE.AX VR1.AX SKN.AX MIN.AX MCT.AX EVE.AX ENX.AX BXN.AX BDGCF BDG.AX AUA.AX AR9.AX TRL.AX TOU.AX SBMSF ROG.AX RLG.AX OVT.AX NXM.AX NC6.AX MRZ.AX MCA.AX LM8.AX IVX.AX HMD.AX GRV.AX GGG.AX EFE.AX DRE.AX DNKLY DNK.L DNK.AX BD1.AX AQI.AX YPB.AX SCT.AX RNE.AX OIEXF OEX.L OEX.AX MLS.AX DEV.AX CXL.AX CMD.AX

Read more →
Published at

Nov 12, 2021 6:25 AM

by stockhead.com.au

mixed

mixed

Closing Bell: ASX closes the week in steady form with a 0.83pc gain

Closing Bell: ASX closes the week in steady form with a 0.83pc gain

XTE.AX VR1.AX TLT.AX SYD.AX SKN.AX MIN.AX MCT.AX IVX.AX EVE.AX ENX.AX DUR.AX DRE.AX BXN.AX BDGCF BDG.AX AUA.AX AR9.AX TRL.AX TOU.AX SBMSF ROG.AX RLG.AX OVT.AX NXM.AX NC6.AX MRZ.AX MCA.AX HMD.AX GRV.AX GGG.AX EFE.AX DNKLY DNK.L DNK.AX BD1.AX AQI.AX YPB.AX SCT.AX RNE.AX OIEXF OEX.L OEX.AX MLS.AX IFT.AX DEV.AX CXL.AX CMD.AX

Read more →
Published at

Nov 10, 2021 8:09 PM

by stockhead.com.au

mixed

mixed

Check Up: Imagion and Invion both target breast cancer clinical trials

Imagion plans to complete enrolment breast cancer Phase I first-in-human study by end of 2021, Invion on the path to clinical trials.

WOW.AX TD1.AX MVF.AX IBX.AX COL.AX ARX.AX ALC.AX ZNO.AX ZLD.AX SOMNF SOM.AX SCU.AX RHY.AX RHT.AX RAP.AX PYC.AX PXSLY PXS.AX PNV.AX PCK.AX PAB.AX OVN.AX OSX.AX OSL.AX NYR.AX NXSCF NXS.AX MDR.AX LBT.AX IMRNW IMRN IMC.AX ICR.AX HCT.AX GLH.AX DVL.AX CYP.AX CMP.AX CDY.AX CALZF BXN.AX BPH.AX BITRF BIT.AX BD1.AX ATX.AX AT1.AX ARUXF AMT.AX ACR.AX 1AD.AX VTG.AX VLS.AX UBI.AX RSH.AX RNO.AX RGS.AX RAC.AX PSQ.AX PGC.AX PBP.AX PAL.AX OPT.AX OPT ONE.AX OIL.AX OCC.AX NOXOF NOX.AX NC6.AX MXC.AX MX1.AX MEM.AX MEB.AX MDC.AX MDBIF LCT.AX KZA.AX KMLXF JHC.AX IVX.AX IUGNF IPDQF IPD.AX IMU.AX IMM.AX IHL.AX IDT.AX GTG.AX GSS.AX FFC.AX FDMDF EYE.AX DXB.AX CPH.AX CKDXF CGS.AX CAN.AX CAJ.AX BWXXF BWX.AX BNOEF BNO.AX AMDHF ADR.AX ADO.AX 4DX.AX 1ST.AX

Read more →
Published at

Oct 27, 2021 9:16 PM

by stockhead.com.au

mixed

mixed

Check Up: Rhythm plans TGA submission and pig tissue MOU fails to impress

Rhythm jumped 33% after it flagged the imminent commercialisation of its ColoSTAT technology.

ZLD.AX TRU.AX RHY.AX RAP.AX PYC.AX PBP.AX OSX.AX OPT.AX OPT ONE.AX NOXOF NOX.AX MEB.AX MDBIF JHC.AX IVX.AX EYE.AX DVL.AX CKDXF BWXXF BWX.AX BNOEF BNO.AX AMT.AX VTG.AX VLS.AX TD1.AX SOMNF SOM.AX SCU.AX RHT.AX PSQ.AX OVN.AX OSL.AX NYR.AX NC6.AX MX1.AX MDR.AX LBT.AX IMRNW IMRN IMC.AX ICR.AX HCT.AX GSS.AX FFC.AX FDMDF CGS.AX BITRF BIT.AX AT1.AX AMDHF ADR.AX 4DX.AX ZNO.AX UBI.AX RSH.AX RNO.AX RGS.AX RAC.AX PXSLY PXS.AX PNV.AX PGC.AX PCK.AX PAL.AX PAB.AX OIL.AX OCC.AX NXSCF NXS.AX MXC.AX MVF.AX MEM.AX MDC.AX KZA.AX KMLXF IUGNF IPDQF IPD.AX IMU.AX IMM.AX IHL.AX IDT.AX GTG.AX GLH.AX DXB.AX CYP.AX CPH.AX CMP.AX CHM.AX CAN.AX CALZF CAJ.AX BXN.AX BPH.AX BD1.AX ATX.AX ARX.AX ARUXF ALT.AX ALC.AX ADO.AX ACW.AX ACR.AX 1ST.AX 1AD.AX

Read more →
Published at

Oct 13, 2021 8:25 PM

by stockhead.com.au

mixed

mixed

Check Up: Fundie says ‘buy the dip’ as biotech loses shine amid pandemic rebound

ASX health stocks have lost some of its shine as the world emerges from the pandemic. The ASX Health index is down 4% this month.

YI SUD.AX RSH.AX MRNA MEM.AX LBT.AX KMLXF GLH.AX FFC.AX FDMDF DVL.AX CPH.AX CDY.AX BWXXF BWX.AX BNOEF BNO.AX ADR.AX 4DX.AX ZNO.AX ZLD.AX RNO.AX RHY.AX RGS.AX RAC.AX PYC.AX PXSLY PXS.AX PNV.AX PGC.AX PBP.AX PAB.AX OSX.AX OSL.AX ONE.AX OCC.AX NC6.AX MVF.AX MDR.AX JHC.AX IPDQF IPD.AX IMRNW IMRN IMC.AX IHL.AX IDT.AX ICR.AX HCT.AX GTG.AX GENE DXB.AX CALZF BPH.AX BD1.AX ATX.AX AT1.AX ARX.AX ARUXF AMT.AX ACR.AX 1ST.AX VTG.AX VLS.AX UBI.AX TD1.AX SOMNF SOM.AX SCU.AX RHT.AX RAP.AX PSQ.AX PCK.AX PAL.AX OVN.AX OPT.AX OPT OIL.AX NYR.AX NXSCF NXS.AX NOXOF NOX.AX MXC.AX MX1.AX MEB.AX MDC.AX MDBIF KZIA KZA.AX IVX.AX IUGNF IMU.AX IMMP IMM.AX GSS.AX EYE.AX CYP.AX CMP.AX CKDXF CGS.AX CAN.AX CAJ.AX BXN.AX BITRF BIT.AX AMDHF ALC.AX ADO.AX 1AD.AX

Read more →
Published at

Sep 28, 2021 9:45 PM

by stockhead.com.au

mixed

mixed

Check Up: Paradigm targets Phase 3 clinical trial in the US; AI microbiology product fails to impress

It’s been a mixed two weeks for small-cap health companies, with 64 companies gaining ground, 47 losing it and 25 flatlining.

RNO.AX RAP.AX PBP.AX LBT.AX IUGNF IMU.AX IMM.AX GLH.AX 1AD.AX ZLD.AX SUD.AX RSH.AX RHT.AX RAC.AX PYC.AX PNV.AX OVN.AX OSX.AX ONE.AX OIL.AX OCC.AX MXC.AX KMLXF IMRNW IMRN IMC.AX HXL.AX DXB.AX CYP.AX CPH.AX CALZF CAJ.AX BWXXF BWX.AX BPH.AX BNOEF BNO.AX BEV.CN BD1.AX AT1.AX AMDHF ALC.AX ZNO.AX VTG.AX VLS.AX UBI.AX TD1.AX SOMNF SOM.AX SCU.AX RHY.AX RGS.AX PXSLY PXS.AX PSQ.AX PGC.AX PCK.AX PAL.AX PAB.AX OSL.AX OPT.AX OPT NYR.AX NXSCF NXS.AX NOXOF NOX.AX NC6.AX MX1.AX MVF.AX MEM.AX MEB.AX MDR.AX MDC.AX MDBIF KZA.AX JHC.AX IVX.AX IPDQF IPD.AX IHL.AX IDT.AX ICR.AX HCT.AX GTG.AX GSS.AX FFC.AX FDMDF EYE.AX DVL.AX CMP.AX CKDXF CGS.AX CAN.AX BXN.AX BITRF BIT.AX ATX.AX ARX.AX ARUXF AMT.AX ADR.AX ADO.AX ACW.AX ACR.AX 4DX.AX 1ST.AX

Read more →
Published at

Sep 16, 2021 4:38 AM

by stockhead.com.au

mixed

mixed

ASX Health Stocks: M&A winds blow as API gets an upgraded offer from Wesfarmers, jumps 15pc

ASX Health Stocks: M&A winds blow as API gets an upgraded offer from Wesfarmers, jumps 15pc

WES.AX HNG.AX HLA.AX EMD.AX CDY.AX BD1.AX

Read more →
Published at

Jul 20, 2021 10:58 PM

by stockhead.com.au

mixed

mixed

Check Up: Rhythm (ASX:RHY) plans US expansion, the US$1.5b dog dermatitis market and data dumps drive stocks down

Check Up: Rhythm (ASX:RHY) plans US expansion, the US$1.5b dog dermatitis market and data dumps drive stocks down

VTG.AX VLS.AX RAP.AX PGC.AX JHC.AX IHL.AX IDT.AX HCT.AX CYP.AX CPH.AX CAN.AX BITRF BIT.AX ATH.AX 1ST.AX ZLD.AX UBI.AX RNO.AX RHY.AX PIQ.AX PCK.AX OCC.AX NC6.AX MXC.AX MVF.AX MEM.AX MDC.AX LSH.AX LBT.AX ICR.AX HXL.AX GLH.AX FDMDF EYE.AX DXB.AX BPH.AX AT1.AX 4DX.AX 1AD.AX ZNO.AX TD1.AX SUD.AX SOMNF SOM.AX SCU.AX RSH.AX RHT.AX RGS.AX RAC.AX PYC.AX PXSLY PXS.AX PSQ.AX PNV.AX PBP.AX PAL.AX PAB.AX OVN.AX OSX.AX OSL.AX OPT.AX OPT ONE.AX OIL.AX NYR.AX NXSCF NXS.AX NOXOF NOX.AX MX1.AX MEB.AX MDR.AX MDBIF KZA.AX KMLXF IVX.AX IUGNF IPDQF IPD.AX IMU.AX IMRNW IMRN IMM.AX IMC.AX GTG.AX GSS.AX FFC.AX DVL.AX CMP.AX CKDXF CGS.AX CALZF CAJ.AX BXN.AX BWXXF BWX.AX BNOEF BNO.AX BD1.AX ATX.AX ARX.AX ARUXF AMT.AX ALT.AX ALC.AX ADR.AX ADO.AX ACR.AX

Read more →
Published at

Jul 7, 2021 11:15 PM

by stockhead.com.au

mixed

mixed

Check up: A mixed bag for ASX health stocks as FDA decides fates at the flip of a coin

Check up: A mixed bag for ASX health stocks as FDA decides fates at the flip of a coin

RSH.AX RHT.AX PNV.AX PCK.AX OCC.AX NOXOF NOX.AX NC6.AX MXC.AX KMLXF IUGNF IMU.AX GTG.AX GSS.AX EYE.AX DVL.AX CDY.AX CALZF BTC.AX VTG.AX UBI.AX TD1.AX SCU.AX RNO.AX RGS.AX PYC.AX PXSLY PXS.AX PSQ.AX PBP.AX OVN.AX OSL.AX ONE.AX OIL.AX NYR.AX NXSCF NXS.AX MVF.AX MEM.AX MEB.AX MDR.AX MDBIF KZA.AX IVX.AX IMRNW IMRN IMM.AX IMC.AX IHL.AX HCT.AX GLH.AX CYP.AX CPH.AX CHM.AX CGS.AX CAN.AX BWXXF BWX.AX BNOEF BNO.AX BITRF BIT.AX AT1.AX ARX.AX 1ST.AX 1AD.AX ZNO.AX ZLD.AX VLS.AX SUD.AX SOMNF SOM.AX RHY.AX RAP.AX RAC.AX PGC.AX PAL.AX PAB.AX OSX.AX OPT.AX OPT MX1.AX MDC.AX LBT.AX JHC.AX IPDQF IPD.AX IDT.AX ICR.AX FFC.AX FDMDF DXB.AX CYC.AX CMP.AX CKDXF CAJ.AX BXN.AX BPH.AX BD1.AX ATX.AX ARUXF AMT.AX ALC.AX ADR.AX ADO.AX ACW.AX ACR.AX 4DX.AX

Read more →
Published at

Feb 15, 2021 5:39 AM

by moneymorning.com.au

positive

positive

BARD1 Life Science Shares Soar a Further 50% on More Positive Data

Last Thursday, the share price of BARD1 Life Sciences Ltd (ASX:BD1) had a massive breakout. Surging by over 100% on the day, snapping the BD1 share price's long sideways momentum...

EGQ.F EGQ.BE BD1.AX

Read more →
Published at

Feb 11, 2021 7:07 AM

by moneymorning.com.au

mixed

mixed

BARD1 Share Price is Up 83% Today — Here’s Why (ASX:BD1)

The BARD1 Life Sciences Ltd (ASX:BD1) share price is up today. This small biotech stock is up 83.22% at time of writing.

BD1.AX EGQ.F EGQ.BE

Read more →